Friday, March 28, 2025
spot_img

Q3 2024 Dividend Exchange Rate

BIRMINGHAM, Ala., March 19, 2025 (GLOBE NEWSWIRE) — Diversified Energy Company PLC (LSE: DEC) (NYSE: DEC) announced on November 12, 2024 a dividend in respect of the quarter ended September 30, 2024 in the amount of 29 cents per share (the “Q3 2024 Dividend”.) The Company will pay the Q3 2024 Dividend on March 31, 2025 to those shareholders on the register on February 28, 2025. 

The Company announces that shareholders who have elected to receive their dividends in GBP sterling will receive an equivalent dividend payment of 22.241 pence per share, based on the March 17, 2025 exchange rate of GBP 0.76693=US $1.00.

For further information, please contact:

Diversified Energy Company PLC +1 973 856 2757
Doug Kris [email protected]
Senior Vice President, Investor Relations & Corporate Communications www.div.energy
   
FTI Consulting [email protected]
U.S. & UK Financial Public Relations  
   

About Diversified Energy Company PLC

Diversified is a leading publicly traded energy company focused on natural gas and liquids production, transport, marketing, and well retirement. Through our differentiated strategy, we acquire existing, long-life assets and invest in them to improve environmental and operational performance until retiring those assets in a safe and environmentally secure manner. Recognized by ratings agencies and organizations for our sustainability leadership, this solutions-oriented, stewardship approach makes Diversified the Right Company at the Right Time to responsibly produce energy, deliver reliable free cash flow, and generate shareholder value.

Powered by SlickText.com

Hot this week

Pieridae Proposes Name Change to Cavvy Energy

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES...

Open Lending to Announce Fourth Quarter and Full Year 2024 Results on March 31, 2025

AUSTIN, Texas, March 27, 2025 (GLOBE NEWSWIRE)...

Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

Encouraging efficacy data in a murine mesothelioma model with...

Abacus Global Management Reports Fourth Quarter and Full Year 2024 Results

- Delivered Record Full Year Revenue and Growth While...

Topics

spot_img

Related Articles

Popular Categories

spot_img